BlackRock Fund Advisors - CLEVELAND BIOLABS INC ownership

CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 20 filers reported holding CLEVELAND BIOLABS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of CLEVELAND BIOLABS INC
ValueSharesWeighting
Q4 2016$1,0000.0%7410.0%0.00%
Q3 2016$1,000
-50.0%
741
+8.3%
0.00%
Q2 2016$2,0000.0%684
+10.3%
0.00%
Q1 2016$2,0000.0%620
+33.0%
0.00%
Q4 2015$2,0004660.00%
Other shareholders
CLEVELAND BIOLABS INC shareholders Q4 2016
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 320,053$1,104,0000.04%
Renaissance Technologies 165,651$571,0000.00%
VANGUARD GROUP INC 52,592$181,0000.00%
UBS Group AG 4,812$17,0000.00%
IFP Advisors, Inc 150$1,0000.00%
OSAIC HOLDINGS, INC. 290$1,0000.00%
BANK OF AMERICA CORP /DE/ 100$00.00%
PNC FINANCIAL SERVICES GROUP, INC. 15,000$52,0000.00%
WELLS FARGO & COMPANY/MN 34$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CLEVELAND BIOLABS INC shareholders